Anthony P Pietropaoli1, Kelly F Henrichs2, Jill M Cholette3, Sherry L Spinelli2, Richard P Phipps1,2,4, Majed A Refaai2, Neil Blumberg2. 1. Department of Medicine, Division of Pulmonary & Critical Care Medicine, University of Rochester Medical Center, Rochester, New York. 2. Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York. 3. Department of Pediatrics, University of Rochester Medical Center, Rochester, New York. 4. Department of Microbiology & Immunology, University of Rochester Medical Center, Rochester, New York.
Abstract
BACKGROUND: Relationships between red blood cell (RBC) transfusion, circulating cell-free heme, and clinical outcomes in critically ill transfusion recipients are incompletely understood. The goal of this study was to determine whether total plasma heme increases after RBC transfusion and predicts mortality in critically ill patients. STUDY DESIGN AND METHODS: This was a prospective cohort study of 111 consecutive medical intensive care patients requiring RBC transfusion. Cell-free heme was measured in RBC units before transfusion and in the patients' plasma before and after transfusion. RESULTS: Total plasma heme levels increased in response to transfusion, from a median (interquartile range [IQR]) of 35 (26-76) μmol/L to 47 (35-73) μmol/L (p < 0.001). Posttransfusion total plasma heme was higher in nonsurvivors (54 [35-136] μmol/L) versus survivors (44 [31-65] μmol/L, p = 0.03). Posttransfusion total plasma heme predicted hospital mortality (odds ratio [95% confidence interval] per quartile increase in posttransfusion plasma heme, 1.76 [1.17-2.66]; p = 0.007). Posttransfusion total plasma heme was not correlated with RBC unit storage duration and weakly correlated with RBC unit cell-free heme concentration. CONCLUSIONS: Total plasma heme concentration increases in critically ill patients after RBC transfusion and is independently associated with mortality. This transfusion-associated increase in total plasma heme is not fully explained by RBC unit storage age or cell-free heme content. Additional studies are warranted to define mechanisms of transfusion-related plasma heme accumulation and test prevention strategies.
BACKGROUND: Relationships between red blood cell (RBC) transfusion, circulating cell-free heme, and clinical outcomes in critically ill transfusion recipients are incompletely understood. The goal of this study was to determine whether total plasma heme increases after RBC transfusion and predicts mortality in critically illpatients. STUDY DESIGN AND METHODS: This was a prospective cohort study of 111 consecutive medical intensive care patients requiring RBC transfusion. Cell-free heme was measured in RBC units before transfusion and in the patients' plasma before and after transfusion. RESULTS: Total plasma heme levels increased in response to transfusion, from a median (interquartile range [IQR]) of 35 (26-76) μmol/L to 47 (35-73) μmol/L (p < 0.001). Posttransfusion total plasma heme was higher in nonsurvivors (54 [35-136] μmol/L) versus survivors (44 [31-65] μmol/L, p = 0.03). Posttransfusion total plasma heme predicted hospital mortality (odds ratio [95% confidence interval] per quartile increase in posttransfusion plasma heme, 1.76 [1.17-2.66]; p = 0.007). Posttransfusion total plasma heme was not correlated with RBC unit storage duration and weakly correlated with RBC unit cell-free heme concentration. CONCLUSIONS: Total plasma heme concentration increases in critically illpatients after RBC transfusion and is independently associated with mortality. This transfusion-associated increase in total plasma heme is not fully explained by RBC unit storage age or cell-free heme content. Additional studies are warranted to define mechanisms of transfusion-related plasma heme accumulation and test prevention strategies.
Authors: Ulrich Salzer; Rong Zhu; Marleen Luten; Hirotaka Isobe; Vassili Pastushenko; Thomas Perkmann; Peter Hinterdorfer; Giel J C G M Bosman Journal: Transfusion Date: 2007-12-07 Impact factor: 3.157
Authors: József Balla; Gregory M Vercellotti; Viktória Jeney; Akihiro Yachie; Zsuzsa Varga; John W Eaton; György Balla Journal: Mol Nutr Food Res Date: 2005-11 Impact factor: 5.914
Authors: Christopher D Reiter; Xunde Wang; Jose E Tanus-Santos; Neil Hogg; Richard O Cannon; Alan N Schechter; Mark T Gladwin Journal: Nat Med Date: 2002-11-11 Impact factor: 53.440
Authors: F A Wagener; A Eggert; O C Boerman; W J Oyen; A Verhofstad; N G Abraham; G Adema; Y van Kooyk; T de Witte; C G Figdor Journal: Blood Date: 2001-09-15 Impact factor: 22.113
Authors: Viktória Jeney; József Balla; Akihiro Yachie; Zsuzsa Varga; Gregory M Vercellotti; John W Eaton; György Balla Journal: Blood Date: 2002-08-01 Impact factor: 22.113
Authors: Marleen Luten; Bregt Roerdinkholder-Stoelwinder; Nicolaas P M Schaap; Willem J de Grip; Harry J Bos; Giel J C G M Bosman Journal: Transfusion Date: 2008-05-13 Impact factor: 3.157
Authors: Elliott Bennett-Guerrero; Tim H Veldman; Allan Doctor; Marilyn J Telen; Thomas L Ortel; T Scott Reid; Melissa A Mulherin; Hongmei Zhu; Raymond D Buck; Robert M Califf; Timothy J McMahon Journal: Proc Natl Acad Sci U S A Date: 2007-10-11 Impact factor: 11.205
Authors: Dávid Pethő; Zoltán Hendrik; Annamária Nagy; Lívia Beke; Andreas Patsalos; László Nagy; Szilárd Póliska; Gábor Méhes; Csaba Tóth; László Potor; John W Eaton; Harry S Jacob; György Balla; József Balla; Tamás Gáll Journal: Sci Rep Date: 2021-05-17 Impact factor: 4.379
Authors: Wiebke Rodieck; Michael Hallensleben; Julia Robert; Oliver Beetz; Gerrit Grannas; Sebastian Cammann; Felix Oldhafer; Juergen Klempnauer; Florian W R Vondran; Ulf Kulik Journal: World J Surg Oncol Date: 2022-03-30 Impact factor: 2.754